he COVID-19 program (like the NASH program) is another “call option,” maybe even further “out of the money.”
Yes - but I hope they continue to work on it. Covid is here to stay in some capacity for years (maybe forever?), and it sure would be nice to have a pill to take. A good DAA would be a big seller even if covid has low prevalence due to concerns about long term effects even in people w "mild" illness
Market Data 
Markets 
